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Abstract 
A simple, specific and precise reverse phase high performance liquid chromatographic method was 
developed and validated for simultaneous estimation of Chlorpromazine and Trihexyphenidyl HCl in tablets. 
Quantification was achieved by using a reverse-phase C18 column (Inertsil ODS 3V, 250 mm x 4.6 mm; 5µ) at 
31
o
C. The mobile phase consisted of a mixture of ammonium acetate buffer and methanol in the ratio of 15:85 
v/v at a flow rate of 1.2 mL/min. The retention times of Chlorpromazine and Trihexyphenidyl HCl were found 
to be 3.237 min and 5.260 min respectively. The developed method was validated as per ICH Guidelines for 
linearity, accuracy, precision, detection limit, quantification limit, ruggedness, robustness, specificity and 
system suitability. The percentage recoveries for both of the drugs from their tablets were found to be 100.34 % 
and 99.80 % respectively. The method may successfully be employed for the simultaneous determination of 
Chlorpromazine and Trihexyphenidyl HCl in pharmaceutical tablet dosage forms. 
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1. Introduction 
Chlorpromazine is a propylamino 
phenothiazine compound, chemically 3-(2-chloro-
10H-phenothiazin -10-yl)-N, N-dimethylpropan-1- 
amine, soluble in methanol. It is a typical anti- 
psychotic drug and acts as an antagonist of 
dopamine-2 receptor. Trihexyphenidyl HCl is 1-
cyclohexyl-1-phenyl-3-(1-piperidyl) propan-1-ol 
hydrochloride. The drug is available as hydrochloride 
salt and slightly soluble in water, soluble in alcohol 
and in chloroform.  Trihexyphenidyl HCl binds to the 
M1 muscarinic receptor and dopamine receptor. It is 
an anti-dyskinetic and anti-parkinson drug. The 
structure of a) Chlorpromazine and b) 
Trihexyphenidyl HCl are shown in figure 1.  
 
Figure 1: Structure of a) Chlorpromazine and b) 
Trihexyphenidyl HCl 
                        
(a)                            (b)                  
 
The literature survey revealed that very few 
RP-HPLC
1-6 
and
 
spectroscopic
7-10
 methods were 
reported for the simultaneous estimation of 
Chlorpromazine and Trihexyphenidyl HCl in 
formulations. The authors now propose a new 
validated, sensitive and reproducible HPLC method 
for simultaneous determination of Chlorpromazine 
and Trihexyphenidyl HCl. The applicability of this 
method in determining the drugs in commercial 
dosage forms were also studied. 
 
2. Experimental 
2.1 Materials 
Standard Trihexyphenidyl HCl and 
chlorpromazine were obtained from SD fine 
chemicals limited (SDFCL), Hyderabad, India. 
Commercial formulation, Talentil T was purchased 
from the local market. Each tablet contains 50 mg of 
Chlorpromazine and 2mg of Trihexyphenidyl HCl. 
Other materials required were HPLC grade water, 
methanol and AR grade Ammonium acetate.  
2.2 Instrumentation  
A Shimadzu LC 20-AT VP high 
performance liquid chromatographic instrument with 
spin chrome software and an inertsil ODS (250 mm x 
4.6 mm; 5µ) column was used for separation. The 
detection was done using an UV – VIS SPD 20A 
Detector. 
2.3 Optimized Chromatographic Conditions  
An inertsil ODS, C18 (250 mm x 4.6 mm; 
5µ) column was used for the analytical separation. 
The mobile phase consisted of a mixture of 0.02M 
ammonium acetate buffer (pH 6) and methanol in the 
ratio of 15:85 v/v with an isocratic elution program. 
The flow rate was adjusted to 1.2 mL/min and the 
injection volume was set at 20 μL with a detection 
wavelength of 215 nm. The separation of 
Chlorpromazine and Trihexyphenidyl HCl under 
optimised conditions is shown in figure 2. 
 
Fig 2: Typical HPLC Chromatogram corresponding to mixed standard solution of Chlorpromazine and 
Trihexyphenidyl HCl 
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2.4 Preparation of Standard solutions: 
2.4.1 Chlorpromazine stock solution:  
50 mg of Chlorpromazine was accurately 
weighed and dissolved in 10mL of the mobile phase. 
After sonication for 15 min, the volume was made 
upto 50mL with the mobile phase to get 1 mg/ mL 
solution. 
2.4.2 Chlorpromazine working standard solutions:  
The Chlorpromazine stock solution was 
diluted suitably with mobile phase to get the working 
standard solutions of concentrations ranging from 60 
to 140 μg/mL. 20 μL of each of the dilutions was 
injected 5 times into the column and the 
chromatograms were recorded. 
2.4.3 Trihexyphenidyl HCl stock solution:  
ihexyphenidyl HCl equivalent to 2 mg of 
Trihexyphenidyl was weighed accurately and 
dissolved in 10 mL of the mobile phase.  After 
sonication for 15 min, the volume was made up to the 
mark with sufficient volume of mobile phase in a 50 
mL volumetric flask to get a 40 μg/mL solution.  
2.4.4 Trihexyphenidyl HCl working standard 
solutions:  
The Trihexyphenidyl HCl stock solution 
was diluted suitably with mobile phase to get the 
working standard solutions of concentrations ranging 
from 2.4 to 5.6 μg/mL. 20 μL of each of the dilutions 
was injected 5 times into the column and the 
chromatograms were recorded. 
2.4.5 Preparation of mixed standard stock 
solution:  
Chlorpromazine (100 mg) and 
Trihexyphenidyl HCl (Equivalent to 4 mg of 
Trihexyphenidyl) were weighed accurately into a 100 
mL volumetric flask, dissolved in 20mL of diluent, 
sonicated for 15 min and the volume was finally 
made up with the mobile phase.  
2.4.6 Preparation of mixed working standard 
solutions:  
1mLof the mixed stock solution was taken 
in a 10 mL volumetric flask and made upto volume 
with the mobile phase to get a concentration 4 μg/mL 
of Trihexyphenidyl HCl and 100 μg/mL of 
Chlorpromazine. 20 μL of this solution was injected 
and the chromatogram was recorded. 
2.5 Preparation of mixed sample solution: 
Twenty tablets were weighed accurately and 
crushed to fine powder. Each tablet contains 50 mg 
of chlorpromazine and 2 mg of Trihexyphenidyl HCl. 
A quantity of powder equivalent to 50 mg of 
Chlorpromazine and 2mg of Trihexyphenidyl HCl 
was weighed and dissolved in 25 mL of the mobile 
phase in a 50 mL volumetric flask. The volume was 
made up to give a concentration of 1000 μg/mL of 
Chlorpromazine and 40 μg/mL of Trihexyphenidyl 
HCl. The solution was filtered through 0.45 μ nylon 
membrane filter. From this filtrate, different dilutions 
ranging from 60-140 μg/mL of Chlorpromazine & 
2.4-5.6 μg/mL of Trihexyphenidyl HCl were 
prepared in 10 mL volumetric flasks with the mobile 
phase. 20 μL of each of these solutions were injected 
5 times and the chromatograms were recorded. The 
amount of Chlorpromazine and Trihexyphenidyl HCl 
present in each tablet formulation was calculated by 
comparing the peak area of the tablet solution with 
that of standard using the given formula: 
 
 
 
2.6 System suitability parameters:  
Five replicates of mixed working standard 
solutions were injected and the parameters like 
theoretical plate number (N), tailing factor (K) and 
resolution are
 
calculated to check the system 
suitability. The results are presented in Table 1. 
Table 1: System suitability test results 
Sr. No Parameters CPZ  THP 
1 Peak area (mV*min) 5835.662 65.058 
2 No. of theoretical plates 4691 2857 
3 Retention time (min) 3.203 5.223 
4 Asymmetry 1.55 1.00 
 
3. Results and Discussion 
            The chromatographic conditions were 
optimised to develop RP-HPLC method for 
simultaneous determination of Chlorpromazine and 
Trihexyphenidyl HCl with adequate resolution and 
rapid analysis time. 
3.1 Method Validation:  
  The analytical method was developed and 
validated according to ICH guidelines. Analytical 
variable parameters such as linearity, precision, 
accuracy, specificity and system suitability were 
tested using the optimized chromatographic 
conditions and instruments. 
3.1.1 Linearity:  
Mixed standard stock solution was suitably 
diluted with the mobile phase to obtain the 
concentrations ranging from 60-140 μg/mL of 
Chlorpromazine & 2.4-5.6 μg/mL of Trihexyphenidyl 
HCl. The solutions were filtered through 0.45 μ nylon 
membrane filter paper and 20 μL of each of the 
solutions were injected and the chromatograms were 
recorded. A good linear relationship (R
2
= 0.997 for 
Chlorpromazine and R
2
= 0.998 for Trihexyphenidyl 
HCl) was observed between the concentrations of the 
drugs and their corresponding peak areas. The results 
of linearity studies are shown in Table 2. 
Table 2: Linearity study data for CPZ and THP 
Sr. No Drugs Slope Intercept Correlation coefficient 
1 Chlorpromazine 37.877 636.88 0.997 
2 Trihexyphenidyl 9.851 2.881 0.998 
 
3.1.2 Accuracy:  
The accuracy studies were performed on 80 
%, 100 % and 120 % of the analytical method target 
concentrations of Chlorpromazine and 
Trihexyphenidyl HCl. Standard and sample 
preparations were injected into HPLC system and 
three determinants for each concentration level were 
obtained. The percentage recoveries of 
Chlorpromazine and Trihexyphenidyl HCl were 
calculated using standard at the same concentration at 
each concentration level. The results are presented in 
Table 3. 
Table 3: Recovery study data for CPZ and THP 
Sr. No Drug %Recovery %RSD 
1 Chlorpromazine 98.02 0.01 
2 Trihexyphenidyl HCl 101.17 0.34 
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3.1.3 Precision: 
System Precision:  
System precision of the proposed method 
was checked by injecting five replicate preparations 
of the standard drug solutions of Chlorpromazine 
(100 μg/ml) and Trihexyphenidyl HCl (4 μg/ml). The 
corresponding peak areas were measured and % RSD 
calculated.  
Method Precision:  
The method precision study was performed 
for five replicate sample preparations of marketed 
formulation containing Chlorpromazine (100 μg/ml) 
and Trihexyphenidyl HCl (4 μg/ml). The 
corresponding peak areas were measured and % RSD 
calculated as exhibited in Table 4. 
Table 4: Precision study data for CPZ and THP 
Sr. No 
Wt. of Sample 
(mg) 
Peak area of Standard Peak area of Sample %Label claim 
CPZ THP CPZ THP CPZ THP 
1 62.50   4310.228 48.681 99.82 99.90 
2 62.47 4318.110 48.725 4310.124 48.723 99.81 100.0 
3 62.65   4309.243 47.995 99.79 98.50 
Mean 99.80 99.46 
S.D 0.0152 0.838 
%RSD 0.015 0.834 
 
3.1.4 Specificity:  
The specificity of the proposed method was 
determined to check whether there is any interference 
due to presence of excipients, impurities or other 
components with the retention time of analytical 
peaks. The HPLC chromatograms were recorded for 
the drug-matrix (mixture of the drug and excipient) 
which showed almost no interfering peaks within 
retention time ranges indicating that the method is 
quite specific. 
3.1.5 Robustness:  
Robustness of the developed analytical 
method was tested by evaluating the affect of small 
variations in analytical method parameters such as 
change in flow rate of 1.2 mL/min by ±0.2 mL/min 
and change in wavelength by ±2 nm. The results are 
shown in Table 5. 
Table 5: Robustness study data for CPZ and THP 
System suitability 
Parameters 
% RSD of peak area 
response   (n=5) 
Mean tailing factor                        
(n=5) 
Mean retention time in 
min. (n=5) 
Variations CPZ THP CPZ THP CPZ THP 
Change in 
Flow rate 
(mL/min) 
+0.2 0.31 0.70 1.47 1.24 3.827 6.197 
0 0.017 0.043 1.55 1.00 3.237 5.260 
-0.2 0.32 0.22 0.73 0.05 2.833 4.590 
Change in 
Wavelength 
(nm) 
+2 0.014 0.044 1.714 1.282 3.233 5.217 
0 0.017 0.043 1.55 1.00 3.237 5.260 
-2 0.029 0.022 1.667 1.037 3.230 5.243 
 
3.2 Application of the method to commercial 
formulation:  
Twenty micro litres of each of the standard 
and sample solutions were injected separately. The 
chromatograms were recorded and the corresponding 
peak areas were measured. The procedure was 
repeated three times, individually weighing the tablet 
powder each time. The peak areas obtained for 
standard and sample were used to calculate the 
amount of each drug in the tablet formulation. The 
results obtained are shown in table 6. The 
chromatogram showing separation of CPZ and THP 
in tablet formulation is shown in figure 3. 
Table 6: Results for tablet formulation study 
Sr. 
No 
Wt. of std. 
(mg) 
Weight of sample 
(mg) 
Peak area of std 
Peak area of 
sample 
%Label claim 
CPZ THP CPZ THP CPZ THP CPZ THP 
1 
50 2 
62.5   4310.228 48.681 100.5 99.90 
2 62.51 4307.870 48.725 4305.171 48.868 99.93 100.29 
3 62.92   4334.100 48.349 100.6 99.22 
Mean 100.343 99.803 
S.D 0.361 0.541 
%RSD 0.35 0.54 
 
Fig 3:  Typical HPLC Chromatogram corresponding to marketed formulation of  
CPZ and THP 
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4. Conclusion 
    The proposed RP-HPLC method is simple, 
sensitive, reproducible, less time consuming and is 
applicable for analysis of Chlorpromazine and 
Trihexyphenidyl HCl in bulk and in tablet dosage 
forms. The method was duly validated by evaluation 
of required parameters. 
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